Guaili Wu
Inventor
Stats
- 2 US patents issued
- 17 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 17 US Applications Filed
- 15 Total Citation Count
- Aug 28, 2020 Most Recent Filing
- Jun 4, 2013 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
JIANGSU HENGRUI MEDICINE CO., LTD. | 2
2 2 1 | 2013
2014 2015 2016 |
Inventor Addresses
Address | Duration |
---|---|
Jiangsu, CN | Apr 12, 16 - Dec 14, 21 |
Lianyungang, CN | Jun 18, 15 - Dec 17, 20 |
Lianyungang, Jiangsu, CN | Apr 14, 16 - Apr 23, 20 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11198683 | 2021 | Method for preparing tyrosine kinase inhibitor and derivative thereof | 0 |
11059810 | 2021 | Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor | 0 |
2020/0392,111 | 2020 | METHOD FOR PREPARING TYROSINE KINASE INHIBITOR AND DERIVATIVE THEREOF | 0 |
2020/0347,039 | 2020 | CRYSTAL FORM OF RENAL OUTER MEDULLARY POTASSIUM CHANNEL INHIBITOR AND PREPARATION METHOD THEREOF | 0 |
10793548 | 2020 | Method for preparing tyrosine kinase inhibitor and derivative thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.